Seminars in Oncology
Volume 35, Issue 1 , Pages 51-63 , February 2008

Evolving Role of Imaging Modalities in Inflammatory Breast Cancer

  • Carisa H. Le-Petross

      Affiliations

    • Department of Diagnostic Radiology, The University of Texas, M.D. Anderson Cancer Center, Houston, TX.
    • ,
  • Luc Bidaut

      Affiliations

    • Department of Imaging Physics, The University of Texas, M.D. Anderson Cancer Center, Houston, TX.
    • ,
  • Wei T. Yang

      Affiliations

    • Department of Diagnostic Radiology, The University of Texas, M.D. Anderson Cancer Center, Houston, TX.
    • Corresponding Author InformationAddress correspondence to Wei T. Yang, MD, Department of Diagnostic Radiology, The University of Texas, M.D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030.

References 

  1. Levine PH, Steinhorn SC, Ries LG, et al. Inflammatory breast cancer: the experience of the Surveillance, Epidemiology, and End Results (SEER) program. J Natl Cancer Inst. 1985;74:291–297
  2. Chang S, Parker SL, Pham T, et al. Inflammatory breast carcinoma incidence and survival: the Surveillance, Epidemiology, and End Results program of the National Cancer Institute, 1975-1992. Cancer. 1998;82:2366–2372
  3. Hance KW, Anderson WF, Devesa SS, et al. Trends in inflammatory breast carcinoma incidence and survival: the Surveillance, Epidemiology, and End Results program at the National Cancer Institute. J Natl Cancer Inst. 2005;97:966–975
  4. Greene FL, Page DL, Fleming ID, et al. American Joint Cancer Committee cancer staging manual. In: 6th ed.. New York: Springer-Verlag; 2002;p. 221–240
  5. Lee B, Tannenbaum N. Inflammatory carcinoma of the breast: a report of twenty-eight cases from the breast clinic of Memorial Hospital. Surg Gynecol Obstet. 1924;39:580–585
  6. Jaiyesimi IA, Buzdar AU, Hortobagyi G. Inflammatory breast cancer: a review. J Clin Oncol. 1992;10:1014–1024
  7. Dirix LY, Dam PV, Prove A, et al. Inflammatory breast cancer: current understanding. Curr Opin Oncol. 2006;18:563–571
  8. Wingo PA, Jamison PM, Young JL, et al. Population-based statistics for women diagnosed with inflammatory breast cancer (United States). Cancer Causes Control. 2004;15:321–328
  9. Dershaw DD, Moore MP, Liberman L, et al. Inflammatory breast carcinoma: mammographic findings. Radiology. 1994;190:831–834
  10. Droulias CA, Sewell CW, McSweeney MB, et al. Inflammatory carcinoma of the breast: a correlation of clinical, radiologic and pathologic findings. Ann Surg. 1976;184:217–222
  11. Gunhan-Bilgen I, Ustun EE, Memis A. Inflammatory breast carcinoma: mammographic, ultrasonographic, clinical, and pathologic findings in 142 cases. Radiology. 2002;223:829–838
  12. Kushwaha AC, Whitman GJ, Stelling CB, et al. Primary inflammatory carcinoma of the breast: retrospective review of mammographic findings. AJR Am J Roentgenol. 2000;174:535–538
  13. Caumo F, Gaioni MB, Bonetti F, et al. Occult inflammatory breast cancer: review of clinical, mammographic, US and pathologic signs. Radiol Med (Torino). 2005;109:308–320
  14. Tardivon AA, Viala J, Corvellec Rudelli A, et al. Mammographic patterns of inflammatory breast carcinoma: a retrospective study of 92 cases. Eur J Radiol. 1997;24:124–130
  15. Lee KW, Chung SY, Yang I, et al. Inflammatory breast cancer: imaging findings. Clin Imaging. 2005;29:22–25
  16. Yang WT, Le-Petross HT, Macapinlac H, et al. Inflammatory breast cancer: PET/CT, MRI, mammography, and sonography findings. Breast Cancer Res Treat. 2007;Epub Jul 26
  17. Chow CK. Imaging in inflammatory breast carcinoma. Breast Dis. 2005;22:45–54
  18. Haagensen CD. Diseases of the breast. In: 2nd Edition. Philadelphia: Saunders; 1971;p. 576–584
  19. Taylor GW, Meltzer A. Inflammatory carcinoma of the breast. Am J Cancer. 1938;133:33–49
  20. Yang WT, Ahuja A, Tang A, et al. High resolution sonographic detection of axillary lymph node metastases in breast cancer. J Ultrasound Med. 1996;16:241–246
  21. Vlastos G, Fornage BD, Mirza NQ, et al. The correlation of axillary ultrasonography with histologic breast cancer downstaging after induction chemotherap. Am J Surg. 2000;179:446–452
  22. Belli P, Costantini M, Romani M, et al. Role of magnetic resonance imaging in inflammatory carcinoma of the breast. Rays. 2002;27:299–305
  23. Rieber A, Tomczak RJ, Mergo PJ, et al. MRI of the breast in the differential diagnosis of mastitis versus inflammatory carcinoma and follow-up. J Comput Assist Tomogr. 1997;21:128–132
  24. Le-Petross HT, Charnsangavej C, Cristofanilli C, et al. Inflammatory breast cancer (IBC): Magnetic resonance imaging (MRI) characteristics at 1.5 and 3.0T. 2007;Presented at the Annual Meeting of the Radiological Society of North America; November 26-30; Chicago, IL
  25. Kuhl CK, Mielcareck P, Klaschik S, et al. Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions?. Radiology. 1999;211:101–110
  26. Anderson WF, Chu KC, Chang S. Inflammatory breast carcinoma and noninflammatory locally advanced breast carcinoma: distinct clinicopathologic entities?. J Clin Oncol. 2003;21:2254–2259
  27. Walshe JM, Swain SM. Clinical aspects of inflammatory breast cancer. Breast Dis. 2005;22:35–44
  28. Wahl RL, Siegel BA, Coleman RE, et al. Prospective multicenter study of axillary nodal staging by positron emission tomography in breast cancer: a report of the Staging Breast Cancer With PET Study Group. J Clin Oncol. 2004;2:277–285
  29. Eubank WB, Mankoff DA. Evolving role of positron emission tomography in breast cancer imaging. Semin Nucl Med. 2005;35:84–99
  30. Osman MM, Cohade C, Nakamoto Y, et al. Clinically significant inaccurate localization of lesions with PET/CT: frequency in 300 patients. J Nucl Med. 2003;44:240–243
  31. Baslaim MM, Bakheet SM, Bakheet R, et al. 18-Fluorodeoxyglucose-positron emission tomography in inflammatory breast cancer. World J Surg. 2003;27:1099–1104
  32. Beyer T, Townsend DW, Brun T, et al. A combined PET/CT scanner for clinical oncology. J Nucl Med. 2000;41:1369–1379
  33. Townsend DW, Beyer T. A combined PET/CT scanner: the path to true image fusion. Br J Radiol. 2002;75(Suppl):24–30
  34. Fueger BJ, Weber WA, Quon A, et al. Performance of 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography and integrated PET/CT in restaged breast cancer patients. Mol Imaging Biol. 2005;7:369–376
  35. Rousseau C, Devillers A, Sagan C, et al. Monitoring of early response to neoadjuvant chemotherapy in stage II and III breast cancer by [18F] fluorodeoxyglucose positron emission tomography. J Clin Oncol. 2006;24:5366–5372
  36. Larson SM, Erdi Y, Akhurst T, et al. Tumor treatment based on visual and quantitative changes in global tumor glycolysis using PET-FDG imaging: the visual response score and the change in total lesion glycolysis. Clin Positron Imaging. 1999;2:159–171
  37. Krak NC, Hoekstra OS, Lammertsma AA. Measuring response to chemotherapy in locally advanced breast cancer: methodological considerations. Eur J Nuc Med Mol Imaging. 2004;31(Suppl 1):S103–S111
  38. Tatsumi M, Cohade C, Mourtzikos KA, et al. Initial experience with FDG-PET/CT in the evaluation of breast cancer. Eur J Nuc Med Mol Imaging. 2006;33:254–262
  39. Bidaut L. Multisensor imaging and virtual simulation for assessment, diagnosis, therapy planning and navigation. Simulation Gaming. 2001;32:370–390
  40. Bidaut L, Akhurst T, Downey RJ. Advanced imaging including PET/CT for cardiothoracic surgery. Semin Thorac Cardiovasc Surg. 2004;16:272–282
  41. Linden HM, Stekhova SA, Link JM, et al. Quantitative fluoroestradiol positron emission tomography imaging predicts response to endocrine treatment in breast cancer. J Clin Oncol. 2006;24:2793–2799
  42. Giger ML. Computerized analysis of images in the detection and diagnosis of breast cancer. Semin Ultrasound CT MR. 2004;25:411–418
  43. Sahiner B, Chan HP, Roubidoux MA, et al. Malignant and benign breast masses on 3D US volumetric images: effect of computer-aided diagnosis on radiologist accuracy. Radiology. 2007;242:716–724
  44. Meinel LA, Stolpen AH, Berbaum KS, et al. Breast MRI lesion classification: improved performance of human readers with a backpropagation neural network computer-aided diagnosis (CAD) system. J Magn Reson Imaging. 2007;25:89–95
  45. Hasegawa BH, Wong KH, Iwata K, et al. Dual-modality imaging of cancer with SPECT/CT. Technol Cancer Res Treat. 2002;1:449–458
  46. Vogel WV, Oyen WJG, Barentsz JO, et al. PET/CT: panacea, redundancy, or something in between?. J Nucl Med. 2004;45(Suppl 1):15S–24S
  47. Van Den Elsen PA, Pol EJD, Viergever MA. Medical image matching—A review with classification. IEEE Engineering Med Biol Magazine. 1993;1:26–39
  48. Crum WR, Griffin LD, Hill DLG, et al. Zen and the art of medical image registration: correspondence, homology and quality. Neuroimage. 2003;20:1425–1437
  49. Crum WR, Hartkens T, Hill DLG. Non-rigid image registration: theory and practice. Br J Radiol. 2007;77:S140–S153
  50. In:  Sonka M,  Fitzpatrick M editor. Handbook of medical imaging. Vol. 2. Medical image processing and analysis. Bellingham, WA: SPIE—The International Society for Optical Engineering; 2000;
  51. Jaffe CC. Measures of response: RECIST, WHO, and new alternatives. J Clin Oncol. 2006;24:3245–3251
  52. Cristofanilli M, Boussen H, Ben Ayed F, et al. A phase II combination study of lapatinib (TYKERB(®) and paclitaxel as neoadjuvant therapy in patients with newly diagnosed inflammatory breast cancer (IBC). 2006;Presented at the 29th San Antonio Breast Cancer Symposium; December 14-17; San Antonio, TX
  53. Wedam SB, Low JA, Yang SX, et al. Antiangiogenic and antitumor effects of Bevacizumab in patients with inflammatory and locally advanced breast cancer. J Clin Oncol. 2006;24:769–777
  54. Hylton N. Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker. J Clin Oncol. 2006;24:3293–3298
  55. Hamstra DA, Rehemtulla A, Ross BD. Diffusion magnetic resonance imaging: a biomarker for treatment response in oncology. J Clin Oncol. 2007;25:4104–4109
  56. Shao Y, Cherry SR, Farahani K, et al. Simultaneous PET and MR imaging. Physics Med Biol. 1997;42:1965–1970
  57. Catana C, Wu Y, Judenhofer MS, et al. Simultaneous acquisition of multislice PET and MR images: initial results with an MR compatible PET scanner. J Nucl Med. 2006;47:1968–1976
  58. Judenhofer MS, Catana C, Swann BK, et al. PET/MR images acquired with a compact MR-compatible PET detector in a 7-T magnet. Radiology. 2007;244:807–814
  59. Schmidt GP, Kramer H, Reiser MF, et al. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology. Topics Magn Reson Imag. 2007;18:193–202
  60. Moy L, Ponzo F, Noz ME, Maguire GQ, et al. Improving specificity of breast MRI using prone PET and fused MRI and PET 3D volume datasets. J Nucl Med. 2007;48:528–537
  61. Shaw CC, Chen L, Altunbas MC, et al. Cone beam breast CT with a flat panel detector—simulation, implementation and demonstration. In: Proceedings of the 27th Annual International Conference of the Engineering in Medicine and Biology Society. 2005;p. 4461–4464
  62. Gong XJ, Glick S, Liu B, et al. A computer simulation study comparing lesion detection accuracy with digital mammography, breast tomosynthesis, and cone beam CT breast imaging. Med Physics. 2006;33:1041–1052
  63. Kwan ALC, Boone JM, Yang K, et al. Evaluation of the spatial resolution characteristics of a cone-beam breast CT scanner. Med Physics. 2007;34:275–281
  64. Levine EA, Freimanis RI, Perrier ND, et al. Positron emission mammography: initial clinical results. Ann Surg Oncol. 2003;10:86–91
  65. Rosen EL, Turkington TG, Soo MS, et al. Detection of primary breast carcinoma with a dedicated, large-field-of-view FDG PET mammography device: initial experience. Radiology. 2005;234:527–534
  66. Duric N, Littrup P, Poulo L, et al. Detection of breast cancer with ultrasound tomography: first results with the Computed Ultrasound Risk Evaluation (CURE) prototype. Med Physics. 2007;34:773–785
  67. Glide C, Duric N, Littrup P. Novel approach to evaluating breast density utilizing ultrasound tomography. Med Physics. 2007;34:744–753
  68. Yates TD, Hebden JC, Gibson AP, et al. Optical tomography of the breast using a multi-channel time-resolved imager. Physics Med Biol. 2005;50:2503–2517
  69. Enfield LC, Gibson AP, Everdell NL, et al. Three-dimensional time-resolved optical mammography of the uncompressed breast. Applied Optics. 2007;46:3628–3638

PII: S0093-7754(07)00241-2

doi: 10.1053/j.seminoncol.2007.11.016

Seminars in Oncology
Volume 35, Issue 1 , Pages 51-63 , February 2008

Article Tools

* Image Usage & Resolution